Corrective unclogging care anti-imperfections skincare anti-marks anti-recurrence
EFFACLAR
DUO (+)

EFFACLAR DUO(+) is a complete care with reinforced anti-imperfection efficacy, to help rapidly clear existing spots, prevent their reappearance and limit the risk of marks.
HOW TO APPLY:
Take a hazelnut-sized amount of cream and warm it to facilitate its absorption. Gently massage into your forehead in light strokes your face.
Anti-imperfections, anti-marks and anti-recurrence.
EFFACLAR DUO(+) shows visible efficacy on imperfections from 12 hours*. This fast result has been demonstrated under dermatological control : skin is significantly less red with a smoother texture.
Prevents marks and offers an anti-recurrence.
*Compilation of studies conducted by La Roche-Posay
Demonstrated efficacy on more than 13000 acne-prone subjects1
- Reduces pimples and blackheads
- Prevents their reappearance
- Limits post-inflammatory hyperpigmentation marks (anti-red and brown marks)
Maintains results 1 month after stopping application2.
Excellent tolerance for 90% of dermatologists and patients3.
Helps protect against the appearance of red or brown marks. Prevents post-acne marks.
B214027/1
EXPERT
QUOTEAvoid friction and scratching when cleansing or applying your skincare. Avoid touching skin as much as possible, keep nails short and avoid sun exposure, as it might worsen blemishes.
Corrective unclogging care anti-imperfections skincare anti-marks anti-recurrence
OR
Anti-imperfections skincare oily acne-prone skin face - women and men
EFFACLAR is a complete range of anti-imperfection solutions that targets all the stages of the imperfection life cycle with a high efficacy, while ensuring a perfect tolerance.
SEVERE IMPERFECTIONS AND MARKS
EFFACLAR is a complete range of anti-imperfection solutions that targets all the stages of the imperfection life cycle with a high efficacy, while ensuring a perfect tolerance.
The 3-step EFFACLAR routine – cleanse, correct, protect – shows proven effectiveness on patients with acne-prone skin living in polluted environments.*
*Quantitative study, Beijing/Shanghai, 2014, Total sample: n=600 ²DIM Sell-in YTD Sept 2015 ³INS/Kantar Health La Roche-Posay Barometers 2013